PHARMACOLOGICAL PROFILE AND INSULIN SECRETAGOGUE EFFECT OF LINOGLIRIDE (MCN-3935), A NEW, ORALLY EFFECTIVE HYPOGLYCEMIC AGENT

被引：11

作者：

TUTWILER, GF ^{[1
]}

TUMAN, RW ^{[1
]}

JOSEPH, JM ^{[1
]}

MIHAN, BB ^{[1
]}

FAWTHROP, H ^{[1
]}

BRENTZEL, HJ ^{[1
]}

机构：

[1] MCNEIL PHARMACEUT,DEPT BIOL RES,ENDOCRINOL & METAB SECT,WELSH & MCKEAN RD,SPRING HOUSE,PA 19477

来源：

DRUG DEVELOPMENT RESEARCH | 1986年 / 9卷 / 04期

关键词：

D O I：

10.1002/ddr.430090405

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：273 / 292

页数：20

共 26 条

[11]

JOHNSON DG, 1980, CLIN RES, V28, pA81

[12]

LEBOVITZ HE, 1984, DIABETES MELLITUS TH, P591

[13]

LEVIN P, 1985, DIABETES S1, V34, pA60

[14] GENERAL PHARMACODYNAMICS OF THE HYPOGLYCEMIC ARYLSULFONAMIDES [J].

LOUBATIERES, A .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1959, 74 (03) :413-418

[15] LACTIC-ACIDOSIS IN BIGUANIDE-TREATED DIABETICS - REVIEW OF 330 CASES [J].

LUFT, D ;

SCHMULLING, RM ;

EGGSTEIN, M .

DIABETOLOGIA, 1978, 14 (02) :75-87

[16]

MARKOWITZ J, 1959, EXPT SURGERY, P347

[17]

MCCARROLL AM, 1985, DIABETES S1, V34, pA195

[18]

PEREIRA JN, 1967, J PHARMACOL EXP THER, V157, P381

[19]

RASMUSSEN CR, 1977, 174TH AM CHEM SOC NA

[20] COMPARISON OF MCN-3495 [N-(1-METHYL-2-PYRROLIDINYLIDENE)-N'-PHENYL-1-PYRROLIDINECARBOXIMIDAMIDE], A NEW, ORALLY EFFECTIVE, HYPOGLYCEMIC AGENT, WITH BIGUANIDES [J].

TUTWILER, GF ;

BRIDI, G .

DIABETES, 1978, 27 (08) :868-876

← 1 2 3 →